Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemours (CC) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $1.3 billion.

  • Chemours' Cost of Revenue rose 327.33% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 billion, marking a year-over-year increase of 339.13%. This contributed to the annual value of $4.6 billion for FY2024, which is 284.76% down from last year.
  • Latest data reveals that Chemours reported Cost of Revenue of $1.3 billion as of Q3 2025, which was up 327.33% from $1.3 billion recorded in Q2 2025.
  • Chemours' 5-year Cost of Revenue high stood at $1.4 billion for Q2 2022, and its period low was $1.1 billion during Q1 2024.
  • For the 5-year period, Chemours' Cost of Revenue averaged around $1.2 billion, with its median value being $1.2 billion (2023).
  • As far as peak fluctuations go, Chemours' Cost of Revenue surged by 5559.28% in 2021, and later crashed by 1184.77% in 2023.
  • Over the past 5 years, Chemours' Cost of Revenue (Quarter) stood at $1.2 billion in 2021, then decreased by 3.81% to $1.1 billion in 2022, then dropped by 2.11% to $1.1 billion in 2023, then dropped by 2.43% to $1.1 billion in 2024, then rose by 16.21% to $1.3 billion in 2025.
  • Its Cost of Revenue was $1.3 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.1 billion in Q1 2025.